Table 2 Correlation panel (Spearman’s test) between endocan and other variables
From: Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patients
Endocan | ||
|---|---|---|
Rho | P | |
AGE | 0.16 | 0.50 |
BMI | 0.35 | 0.13 |
SBP | -0.11 | 0.68 |
DBP | -0.27 | 0.31 |
TC mg/dl | 0.12 | 0.67 |
TG mg/dl | -0.27 | 0.34 |
HDL mg/dl | -0.11 | 0.68 |
LDL-C mg/dl | 0.30 | 0.21 |
NHDL mg/dl | 0.20 | 0.39 |
GLUCOSE mg/dl | 0.02 | 0.92 |
INSULIN μU/ml | 0.47 | 0.04 |
HOMA-IR | 0.43 | 0.07 |
STEATOSIS (YES) | 0.51 | 0.08 |
STEATOSIS GRADING | 0.51 | 0.08 |